Full-text resources of CEJSH and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

Results found: 2

first rewind previous Page / 1 next fast forward last

Search results

help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
1
Publication available in full text mode
Content available

Informed Consent for the Use of AI in the Process of Providing Medical Services

100%
Wałdoch K.
Review of European and Comparative Law
|
2024
|
vol. 57
|
issue 2
121-134
EN
It has been for several years now that physicians use medical devices based on artificial intelligence (AI) in their professional practice. The use of these tools makes health services more personalized, tailored to the individual characteristics and needs of the patient. There is also a technological possibility for AI systems to provide patients with information regarding their health condition and treatment methods. The use of medical devices equipped with AI creates new types of risk, including the risk of algorithmic error, the risk of cyber-attack, and the risk of algorithmic mismatch (false-positive or false-negative results). Most patients do not know these tools, so not everyone will trust them. Obtaining informed consent from the patient is a necessary condition for any medical intervention. This study attempts to answer the following questions: (1) Is there a legal possibility to provide AI with the ability to inform the patient about their health condition and proposed treatment methods?; (2) Does the unpredictability and opacity of AI behavior affect the scope of information that should be provided to the patient before medical intervention?; (3) What information should the physician provide to the patient for this consent to be considered informed?; (4) Should the patient always be informed that AI was involved in the diagnosis or therapeutic process? The presented study uses comparative law methodology. American, Belgian and German law are analysed. Is there a legal possibility to provide AI with the ability to inform the patient about his health condition and proposed treatment methods? Does the unpredictability and opacity of AI behavior, affect the scope of information that should be provided to the patient before medical intervention? What information should the physician provide to the patient for this consent to be considered informed? Should the patient always be informed that an AI was involved in the diagnosis or therapeutic process? The comparative law methodology was used in this study. American, Belgian and German law were analyzed.
2
Publication available in full text mode
Content available

Rozszerzenie kręgu podmiotów uprawnionych do skorzystania ze szczególnej ochrony konsumenckiej

100%
Wałdoch K.
Studia Iuridica
|
2021
|
vol. 88
442-455
EN
The article aims to analyze and evaluate the last amendment of the Civil Code by which articles 3855, 5564, 5765 enter into force. These regulations are expanding the group of entities entitled to consumer protection. New provisions, by the intention of the legislator, are to provide entrepreneurs who are natural persons concluding contracts with entrepreneurs with the stronger market position the same protection as provided for consumers in the scope of the use of abusive clauses, warranty for defects and the right to withdraw from a distance or off-premises contract. The introduced regulation raises some theoretical and practical doubts. They result from the unclear terms used by the legislator and from giving decisive importance to the data contained in CEIDG when qualifying contracts in terms of their professional nature.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.